Drug Profile
Filgrastim biosimilar - Zydus Cadila
Alternative Names: G-CSF - Zydus CadilaLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator Zydus Cadila
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists; Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 28 Feb 2014 Launched for Neutropenia in India (SC)